Position in GH
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$8,251
+$2,894 QoQ
Shares Held
55
-5.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#526
of 593 holders
Holding Since
Dec 2020
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026JFS WEALTH ADVISORS, LLC holds $571,735 across 20 Diagnostics & Research names. GH ranks #14 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
333 | $166,952 | |
| 2 | IQV |
Iqvia Holdings Inc.
|
653 | $126,172 | |
| 3 | RVTY |
Revvity, Inc.
|
424 | $47,174 | |
| 4 | DHR |
Danaher Corp /De/
|
203 | $38,667 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
|
62 | $32,639 | |
| 6 | DGX |
Quest Diagnostics Inc
|
133 | $28,189 | |
| 7 | WAT |
Waters Corp /De/
|
60 | $22,502 | |
| 8 | A |
Agilent Technologies, Inc.
|
128 | $17,002 |
All Filings in GH
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,251 | 55 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $5,357 | 58 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $5,719 | 56 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $1,936 | 31 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $1,613 | 31 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $724 | 17 | Shares | Sole | 2025-04-22 | |
| 2023-12-31 | $595 | 22 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $88 | 3 | Shares | Sole | 2023-11-02 | |
| 2022-03-31 | $1,059 | 16 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $800 | 8 | Shares | Sole | 2022-02-03 | |
| 2020-12-31 | $3,608 | 28 | Shares | Sole | 2021-02-01 | |
| No filing history on record for this holder in this stock. | ||||||